About: Roles and contributions of pharmacists in regulatory affairs at the Centers for Disease Control and Prevention for public health emergency preparedness and response

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Roles and contributions of pharmacists in regulatory affairs at the Centers for Disease Control and Prevention for public health emergency preparedness and response Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Roles and contributions of pharmacists in regulatory affairs at the Centers for Disease Control and Prevention for public health emergency preparedness and response
Source	Elsevier; Medline; PMC
abstract	OBJECTIVE: To provide a general description of the roles and contributions of three pharmacists from the Regulatory Affairs program (RA) at the Centers for Disease Control and Prevention (CDC) who are involved in emergency preparedness and response activities, including the 2009 pandemic influenza A (H1N1) public health emergency. SETTING: Atlanta, GA. PRACTICE DESCRIPTION: RA consists of a staff of nine members, three of whom are pharmacists. The mission of RA is to support CDC's preparedness and emergency response activities and to ensure regulatory compliance for critical medical countermeasures against potential threats from natural, chemical, biological, radiological, or nuclear events. CONCLUSION: RA was well involved in the response to the H1N1 outbreak through numerous activities, such as submitting multiple Emergency Use Authorization (EUA) requests to the Food and Drug Administration, including those for medical countermeasures to be deployed from the Strategic National Stockpile, and developing the CDC EUA website (www.cdc.gov/h1n1flu/eua). RA will continue to support current and future preparedness and emergency response activities by ensuring that the appropriate regulatory mechanisms are in place for the deployment of critical medical countermeasures from the Strategic National Stockpile against threats to public health.
has issue date	2015-12-31(xsd:dateTime)
bibo:doi	10.1331/japha.2010.09220
bibo:pmid	20199957
has license	no-cc
sha1sum (hex)	a778ccfb7c1f8c36aadd62218ffa7a2a99a8ec1d
schema:url	https://doi.org/10.1331/japha.2010.09220
resource representing a document's title	Roles and contributions of pharmacists in regulatory affairs at the Centers for Disease Control and Prevention for public health emergency preparedness and response
has PubMed Central identifier	PMC7110961
has PubMed identifier	20199957
schema:publication	J Am Pharm Assoc (2003)
resource representing a document's body	covid:a778ccfb7c1f8c36aadd62218ffa7a2a99a8ec1d#body_text
is schema:about of	named entity 'ORIGINAL SOURCE' named entity 'PHARMACISTS' named entity 'MEANS' named entity 'SPECIAL' named entity 'R M' named entity 'OBJECTIVE' named entity 'RESOURCE' named entity 'WWW' named entity 'USE' named entity '165' named entity 'THESE' named entity 'DESCRIPTION' named entity 'RIGHTS' named entity 'ABSTRACT' named entity 'O C' named entity 'ORG' named entity 'COVID-19' named entity '80%' named entity 'FEATURE' named entity '50%' named entity 'ACTIVE' named entity 'S T' named entity 'A N' named entity 'PERMISSIONS' named entity 'FUNDED' named entity 'FORM' named entity 'FREE' named entity 'REPOSITORIES' named entity 'LONG' named entity 'ROLES' named entity 'GENERAL' named entity 'CENTRE' named entity 'TO PROVIDE' named entity 'DATABASE' named entity 'RESEARCH' named entity 'A T' named entity 'UNRESTRICTED' named entity 'REGULATORY' named entity 'JAPhA' named entity 'granted' named entity 'Regulatory' named entity 'Elsevier' named entity 'database' named entity 'regulatory compliance' named entity 'EUA' named entity 'life-threatening' named entity 'pediatrics' named entity 'pharmaceutical companies' named entity 'medical emergency' named entity 'CDC' named entity 'chemical, biological, radiological' named entity 'disease prevention' named entity 'health care providers' named entity 'public health' named entity 'H1N1' named entity 'medical countermeasures' named entity 'pediatric patients' named entity 'Influenza' named entity 'CDC' named entity 'medical countermeasures' named entity 'Strategic National Stockpile' named entity 'health care personnel' named entity 'CDC' named entity 'oseltamivir' named entity 'attacks of September 11, 2001' named entity 'medical countermeasures' named entity 'EUA' named entity 'EUA' named entity 'adverse event' named entity 'Secretary of HHS' named entity '2009 H1N1' named entity 'CBRN' named entity 'medical countermeasures' named entity 'microbiology' named entity 'inhalation' named entity 'peramivir' named entity 'smallpox' named entity 'GlaxoSmithKline' named entity 'FDA' named entity 'medical countermeasures' named entity 'FDA' named entity 'CBRN'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software